← All stocks

Humacyte, Inc.

HUMA Net buying
CIK 0001818382 #3976 in the set updated 17 Sep 2026
Bought (1 mo)
$30.37K
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$30.37K
+$30.37K against sales at will

By person

9 insiders · 3 transactions
0.2×

Laura E. Niklason holds only 0.2 times base salary in stock. $137.04K of shares against $633.61K in salary for 2025.

Salary from the company's own proxy. The shares are what Laura E. Niklason last reported holding, valued at $0.56, the price Common Stock was last bought or sold at on the open market here, on 14 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Jones Keith Anthony
Director
$30.37K (3)
+$30.37K
50,000
$28.10K
Sander Dale A.
CFO and Chief Corp. Dev. Off
307,813
$172.99K
+1,262%
Parikh Shamik J
Chief Medical Officer
272,713
$153.26K
Niklason Laura E
President, CEO and Director
243,851
$137.04K
−93.9%
Sebelius Kathleen
Director
148,025
$83.19K
+259.2%
Constantino Michael T.
Director
43,950
$24.70K
+255.9%
Scheessele William John
Chief Commercial Officer
22,018
$12.37K
+41.8%
Green Charles Bruce
Director
8,400
$4.72K
+250.0%
Dougan Brady W
Director
0
$0.00
−100.0%

No percentages here. This company's share count has moved by a factor of 2.2 over the window, from 125,859,496 to 277,798,105 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Jones Keith Anthony
14 Sep 2026
Director
Buy
10,000
$0.56
$5.62K
Jones Keith Anthony
20 Aug 2026
Director
Buy
10,000
$0.69
$6.93K
Jones Keith Anthony
17 Aug 2026
Director
Buy
30,000
$0.59
$17.82K

What was left out

Form 4 filings counted 3
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 23 Sep 2020